The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Peg and Smoking Risks
Mar 4, 2001

We are currently preparing to start the new PEG Interferon alfa-2b plus Ribavirin Study we recieved an Informed Consent which had a section on risks that said you must not be at high for disease, Smoking etc. Well my husband is a smoker and the Drs. office could not answer this question "What are the risks of taking this treatment and smoking?" This study is being done by a Dr. Ira Jacobson at the New York Presbyterian Hospital and when I called there I was told that they couldn't give me any info. Are there side effects such as lung cancer/smoking and the treatment itself? I don't know if we should participate in this study or not?


Response from Dr. Rodriguez-Torres

There is no contraindication of smoking while using peg-interferons.Smoking is associated with more severity of hepatitis C and we reccomend the patients to decrease or stop . There is no relationship to my knowledge between interferon and increased risk of lung cancer in smokers.

side effects of interferon
HIV+,Hepc+, and antidepressants

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint